X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-03-19 | SOPH | Van Well Daan | GC | S - Sale | $4.79 | -684 | 261,238 | 0% | -$3,274 | ||||||
2026-03-19 | SOPH | Camblong Jurgi | CEO | S - Sale | $4.77 | -4,486 | 3,302,839 | 0% | -$21,410 | ||||||
2026-03-19 | SOPH | Menu Philippe | Chief Medical Officer | S - Sale | $4.79 | -608 | 173,616 | 0% | -$2,913 | ||||||
2026-03-19 | SOPH | Xu Zhenyu | Chief Scientific Officer | S - Sale | $4.78 | -608 | 537,116 | 0% | -$2,907 | ||||||
2026-03-19 | SOPH | Valente Manuela | Chief People Officer | S - Sale | $4.79 | -380 | 152,379 | 0% | -$1,818 | ||||||
2026-03-19 | SOPH | Muken Ross | Pres | S - Sale | $4.79 | -1,183 | 271,910 | 0% | -$5,671 | ||||||
2026-03-19 | SOPH | Puylaert Kevin | Chief Sales Officer | S - Sale | $4.76 | -33 | 92,386 | 0% | -$157 | ||||||
2026-03-19 | SOPH | Cardoza George | CFO | S - Sale | $4.79 | -774 | 184,858 | 0% | -$3,705 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |